SPL 3.13% 9.9¢ starpharma holdings limited

New xxsbiz interview on Starpharma/Medicxi $38 million deal, page-7

  1. 872 Posts.
    lightbulb Created with Sketch. 57
    If you watched the webinar, the CEO of Petalion indicated 3-4 years not once but twice and even sooner to exit and monetize if inflection points on the way were better than anticipated????

    Perhaps in the meantime we could work on Viraleze and vivagel, we know they are both effective if you believe Scipps Laboratories testing !!!!
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.